global glp-1 market size 2025 Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Receptor Agonist Market Valued

For weight loss specifically, Wegovy (same active ingredient, different dose) is the obesity-approved version, and coverage for that varies widely by state

Nguyen B, Bix G, Yao Y

von Loeffelholz C, Docke S, Lock JF, Lieske S, Horn P, Kriebel J, Wahl S, Singmann P, de Las Heras Gala T, Grallert H, Raschzok N, Sauer IM, Heller R, Jahreis G, Claus RA, Bauer M, Stockmann M, Birkenfeld AL, Pfeiffer AFH (2017) Increased lipogenesis in spite of upregulated hepatic 5AMP-activated protein kinase in human non-alcoholic fatty liver

On April 22, 2025 , DSM-Firmenich entered into strategic collaborations with biotechnology firms to develop advanced delivery systems such as liposomal and nano-formulated glutathione, improving stability and bioavailability for dietary supplements and pharmaceutical applications